Signaling Pathway Inhibitors
Over 20,000 selective inhibitors and agonists targeting kinases, GPCRs, ion channels, epigenetic enzymes, and nuclear receptors — with comprehensive IC50 and selectivity data.
Product Categories
TargetMol Product Range
20,000+ compounds, 800+ libraries — spanning inhibitors, natural products, and FDA-approved drugs for drug discovery and biological research.
Compound Libraries (800+)
Curated HTS-ready libraries: FDA-approved drugs, bioactive compounds, kinase-focused sets, GPCR-targeted libraries, anti-cancer sets, and fragment libraries — supplied in DMSO or powder format.
Natural Products (16,000+)
Isolated and purified natural compounds from plants, fungi, and marine organisms. Structures confirmed by NMR and HPLC — ideal for bioactivity screening and drug lead identification.
Peptides & Assay Kits
Custom-synthesized peptides and ready-to-use assay kits (apoptosis, autophagy, kinase activity, oxidative stress) that simplify in vitro mechanistic studies and drug target validation.
Anti-Cancer Compound Sets
Targeted oncology compound collections covering approved chemotherapeutics, PARP inhibitors, CDK inhibitors, immunotherapy agents, and next-generation targeted therapies.
Virtual Screening & CADD Services
Computer-aided drug design services: molecular docking, virtual screening, ADMET prediction, and custom synthesis to accelerate your drug discovery pipeline from hit to lead.
Source TargetMol Products in India
Inhibitors, compound libraries, and natural products with competitive pricing and expert guidance from Bio Solutions India.